Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2.
about
Regulatory Crosstalk by Protein Kinases on CFTR Trafficking and Activity.CFTR: a hub for kinases and crosstalk of cAMP and Ca2+Understanding protein kinase CK2 mis-regulation upon F508del CFTR expressionContribution of casein kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein kinase A-induced activity.Casein kinase 2α regulates multidrug resistance-associated protein 1 function via phosphorylation of Thr249.The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design.CFTR mutations altering CFTR fragmentation.Purinergic signalling in epithelial ion transport: regulation of secretion and absorption.Protein kinase CK2 inhibitors: a patent review.Casein kinases as potential therapeutic targets.Expression of wild-type CFTR suppresses NF-kappaB-driven inflammatory signalling.Strategies for the etiological therapy of cystic fibrosis.A "SYDE" effect of hierarchical phosphorylation: possible relevance to the cystic fibrosis basic defect.NM23 proteins: innocent bystanders or local energy boosters for CFTR?The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131.
P2860
Q26770258-057D5451-86C4-45C3-8BBD-E9476DA4EBC3Q26999235-03199294-D876-460C-97DF-6E26FA2C512BQ27694649-3C614680-87B8-452D-99A5-267F1D3B8F77Q34022687-0D68A73B-2C8B-4C78-BD54-C2F2DDDDD76CQ36174733-852C24B7-0601-449D-A667-B12EC4FCF490Q36288208-6BA656FB-74AE-44ED-A36B-A6D1D06CA9A9Q36525714-4E73F8D4-D7F9-423D-9B22-36C200BD19E9Q37809120-439C8C8B-8E04-41C8-B661-F3D2DDC5D9B7Q38036342-C5A8334D-BAD6-44DB-A2D4-B44E113CE455Q38632634-F3E338E3-37E2-41E3-A430-C0E746F61804Q39678214-CE41A82A-10B0-4543-B4CF-47FA6AE9DC32Q42650380-202C2B60-D392-4BF6-923B-A722D729F6D5Q46326870-6608DF27-B88A-447E-AAF4-13379A370BA1Q47281925-2437E4AB-DC64-4C02-A2B3-D95C90DF17D4Q54982621-0F4B582F-D70F-469F-A7F7-87285E4485E5
P2860
Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cystic fibrosis transmembrane ...... ol over the master kinase CK2.
@ast
Cystic fibrosis transmembrane ...... ol over the master kinase CK2.
@en
Cystic fibrosis transmembrane ...... ol over the master kinase CK2.
@nl
type
label
Cystic fibrosis transmembrane ...... ol over the master kinase CK2.
@ast
Cystic fibrosis transmembrane ...... ol over the master kinase CK2.
@en
Cystic fibrosis transmembrane ...... ol over the master kinase CK2.
@nl
prefLabel
Cystic fibrosis transmembrane ...... ol over the master kinase CK2.
@ast
Cystic fibrosis transmembrane ...... ol over the master kinase CK2.
@en
Cystic fibrosis transmembrane ...... ol over the master kinase CK2.
@nl
P2093
P2860
P50
P356
P1433
P1476
Cystic fibrosis transmembrane ...... ol over the master kinase CK2.
@en
P2093
Anil Mehta
Flavio Meggio
Kate J Treharne
Oriano Marin
P2860
P356
10.1042/BJ20090813
P407
P577
2010-01-27T00:00:00Z